Meet the Experts

Portrait of Eric Pujade-Lauraine
Biography Disclosures

Prof. Eric Pujade-Lauraine

Go Back

Gynaecologic Oncologist

  • Hôpital Hôtel-Dieu
  • location France
Biography Disclosures
Prof. Eric Pujade-Lauraine has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Clovis, Pfizer, Roche and Tesaro. 

Programmes developed by Prof. Eric Pujade-Lauraine

The role of DDR and PARP inhibition (PARPi) in oncology » COR2ED Other
Oncology 
The Role of DDR and PARP inhibition (PARPi) in Oncology – BluePrints

Experts
Dr Violeta Serra, Prof. Jonathan A. Ledermann, Prof. Eric Pujade-Lauraine, Prof. Simon Boulton, Dr Mark J. O'Connor, Prof. Charlie Gourley, Dr Judith Balmaña, Prof. Sibylle Loibl
  • download Downloadable
    Resources
  • clock MIN
  • calendar Sep 2021
COR2ED
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca
Review paper published in Journal of Clinical Oncology » COR2ED
Oncology 
Moving from PARP Inhibition to Targeting DNA Repair and DDR in Cancer Therapy

Experts
Dr Judith Balmaña, Dr Rebecca Dent, Prof. Simon Boulton, Prof. Sibylle Loibl, Prof. Eric Pujade-Lauraine, Prof. Charlie Gourley, Dr Violeta Serra, Prof. Jonathan A. Ledermann
  • download Downloadable
    Resources
  • clock 10 MIN
  • calendar Sep 2021
COR2ED
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca
E-learning The role of PARP inhibition in clinical practice » COR2ED Interactive e-learning
Oncology 
The Role of PARP Inhibition in Clinical Practice

Experts
Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine
  • clock 60 MIN
  • calendar Sep 2021
COR2ED EACCME
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca
Explore all our programmes